APA (7th ed.) Citation

LS, G., C, P., L, I., D, I., AE, C., CS, P., . . . M, M. (2020). Efficacy and Safety of Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: A Cohort Study. Journal of gastrointestinal and liver diseases : JGLD, 29(3), 385. https://doi.org/10.15403/jgld-2448

Chicago Style (17th ed.) Citation

LS, Gheorghe, et al. "Efficacy and Safety of Ledispavir/Sofosbuvir with or Without Ribavirin in Patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: A Cohort Study." Journal of Gastrointestinal and Liver Diseases : JGLD 29, no. 3 (2020): 385. https://doi.org/10.15403/jgld-2448.

MLA (9th ed.) Citation

LS, Gheorghe, et al. "Efficacy and Safety of Ledispavir/Sofosbuvir with or Without Ribavirin in Patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: A Cohort Study." Journal of Gastrointestinal and Liver Diseases : JGLD, vol. 29, no. 3, 2020, p. 385, https://doi.org/10.15403/jgld-2448.